Severe diabetic ketoacidosis precipitated by an atypical antipsychotic drug

Bahrain Medical Bulletin

Volumn 29, Issue 4, 2007, Pages 143-145

  Niazy, Mohammad Naeem ^a   Baidas, Ghassan ^a   Neyyarapally, Thomas Isaac ^a   Shuja Ud Din, ^a  

^a AL SABAH HOSPITAL   (Kuwait)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; OLANZAPINE; RISPERIDONE;

ADULT; ARTICLE; CASE REPORT; CONFUSION; DEHYDRATION; DIABETIC KETOACIDOSIS; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HUMAN; MALE; POLYDIPSIA; POLYURIA; SCHIZOPHRENIA; SINUS TACHYCARDIA; STUPOR;

EID: 36949032552     PISSN: 10128298     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. On behalf of the American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, North American Association for the Study of Obesity. Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes. Diabetes Care 2004; 27(2):596-601.
2. Cohen D, Stolk RP, Grobbee DE, et al. Hyperglycemia and Diabetes in Patients with Schizophrenia and Schizoaffective Disorders. Diabetes Care 2006; 29(4):786-91.
3. Maria D. Llorente, Victoria Urrutia, Psychiatric Disorders and the Metabolic Effects of Anti Psychotic Medications. Clinical diabetes 2006; 24:18-24.
4. Koller EA, Doraiswamy PM. Olanzapine Associated Diabetes mellitus. Pharmacotherapy 2002; 22(7):841-52.
5. Koro CE, Fedder DO, L'Italian GJ, et al. Assessment of Independent Effect of Olanzapine and Risperidone on Risk of Diabetes among Patients with Schizophrenia: Population Based Nested Case-control Study. BMJ 2002; (3)325:243.
6. Lindenmayer JP, Nathan AM, Smith C. Hyperglycemia Associated with the Use of Atypical Antipsychotics. J Clin Psychiatry. 2001; 62(23):30-38.
7. Meyer JM. A Retrospective Comparison of Lipid, Glucose, and Weight Changes at One Year between Olanzapine - and Risperidone-treated Inpatients. Biol Psychiatry 2002; 63(5):425-33.
8. Goldstein LE, Sporn J, Brown S, et al. New-onset Diabetes Mellitus and Diabetic Ketoacidosis Associated with Olanzapine Treatment. Psychosomatics 1999; 40:438-43.
9. Melkersson KI, Hultin AL, Brismar KE. Different Influences of Classical Antipsychotics and Clozapine on Glucose-insulin Homeostasis in Patients with Schizophrenia or Related Psychoses. J Clin Psychiatry 1999; 60:783-91.
10. Johnson DE, Yama Zaki H, Ward KM, et al. Inhibitory Effects of Antipsychotics on Carbachol-enhanced Insulin Secretion from Perfused Rat Islets: Role of Muscarinic Antagonism in Antipsychotic Induced Diabetes and Hyperglycemia. Diabetes 2005; 54:1552-8.
11. Howes OD, Rifkin L. Diabetic Ketoacidotic (DKA) Coma Following Olanzapine Initiation in a Previously Euglycemic Woman and Successful Continued Therapy with Olanzapine. Journal of psycho-pharmacology 2004; 18(3):435-7.